A study of the relationship between placenta growth factor and gestational age, parturition, rupture of membranes, and intrauterine infection

American Journal of Obstetrics and Gynecology

Volumn 182, Issue 6, 2000, Pages 1633-1637

  Seubert, David E ^b   Maymon, Eli ^a   Pacora, Percy ^a   Gervasi, Maria Teresa ^a   Berry, Stanley M ^b   Torry, Donald S ^c   Romero, Roberto ^a,b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b HUTZEL HOSPITAL   (United States)

^c UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

Author keywords

Amniotic fluid; Angiogenesis; Intra amniotic infection; Placenta growth factor; Preterm labor; Rupture of membranes

Indexed keywords

ANGIOGENIC FACTOR; GROWTH FACTOR;

AMNION FLUID; CHILDBIRTH; CONFERENCE PAPER; DIAGNOSTIC VALUE; FEMALE; GESTATIONAL AGE; HUMAN; INTRAUTERINE INFECTION; MAJOR CLINICAL STUDY; PLACENTA DEVELOPMENT; PRIORITY JOURNAL;

EID: 0033916514     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2000.107437     Document Type: Article

References (25)

1. 1. Jaffe R, Jauniaux E, Hustin J. Maternal circulation in the first-trimester human placenta - myth or reality? Am J Obstet Gynecol 1997;176:695-705.
2. 2. Klagsbrun M, D'Amore P. Regulators of angiogenesis. Ann Rev Physiol 1991;53:217-39.
3. 3. Reynolds LP, Killilea SD, Redmer DA. Angiogenesis in the female reproductive system. FASEB J 1992;6:886-92.
4. 4. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989;161:1049-59.
5. 5. Krebs C, Macara LM, Leiser R, Bowman AW, Greer IA, Kingdom JC. Intrauterine growth restriction with absent end-diastolic flow velocity in the umbilical artery is associated with maldevelopment of the placental terminal villous tree. Am J Obstet Gynecol 1997;176:695-705.
6. 6. Burgos H. Angiogenic and growth factors in human amniochorion and placenta. Eur J Clin Invest 1993;13:289-96.
7. 7. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996;380:439-42.
8. 8. Shore VH, Wang TH, Wang CL, Torry RJ, Caudle MR, Torry DS. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. Placenta 1997; 18:657-65.
9. 9. Fong GH, Rossant J, Gertsenstein M, Breitman ML. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995;376:66-70.
10. 10. Millauer B, Wizigmann-Voos S, Schnurch H, Martinez R, Moller NPH, Risau W, et al. High affinity VEGF binding and developmental expression suggest flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell Vol 1993;72:835-46.
11. 11. Ahmed A, Li XF, Dunk C, Whittle MJ, Rushton DI, Rollason T. Colocalisation of vascular endothelial growth factor and its Flt-1 receptor in human placenta. Growth Factors 1995;12: 235-43.
12. 12 Shiraishi S, Nakagawa K, Kinukawa N, Nakano H, Sueishi K. Immunohistochemical localization of vascular endothelial growth factor in the human placenta. Placenta 1996;17:111-21.
13. 13. Vuckovic M, Ponting J, Terman BI, Niketic V, Seif MW, Kumar S. Expression of the vascular endothelial growth factor receptor, KDR, in human placenta. J Anat 1996;188:361-6.
14. 14. Clark DE, Smith SK, Sharkey AM, Charnock-Jones DS. Localization of VEGF and expression of its receptors flt and KDR in human placenta throughout pregnancy. Hum Reprod 1996;11: 1090-8.
15. 15. Baker PN, Krasnow J, Roberts JM, Yeo KT. Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia. Obstet Gynecol 1995;86:815-21.
16. 16. Sharkey AM, Cooper JC, Balmforth JR, McLaren J, Clark DE, Charnock-Jones S, et al. Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by preeclampsia. Eur J Clin Invest 1996;26:1182-5.
17. 17. Khaliq A, Li XF, Shams M, Sis P, Acevedo CA, Whittle MJ, et al. Localisation of placenta growth factor in human term placenta. Growth Factors 1986;13:243-50.
18. 18. Ziche M, Maglione D, Ribatti D, Morbidelli L, Lago CT, Battisi M, et al. Placenta growth factor-1 is chemotactic, mitogenic and angiogenic. Lab Invest 1997;76:517-31.
19. 19. Torry DS, Wang H, Wang T, Caudle M, Torry RJ. Preeclampsia is associated with reduced serum levels of placental growth factor. Am J Obstet Gynecol 1998;179:1539-44.
20. 20. Shifren JL, Doldi N, Ferrera N, Mesiano S, Jaffe RB. In the human fetus, vascular endothelial growth factor is expressed in epithelial cells and myocytes, but not vascular endothelium: implications for mode of action. J Clin Endocrinol Metab 1994; 79:316-22.
21. 21. Vuorela-Vepsalainen P, Alfthan H, Orpana A, Alitalo K, Stenman U-H, Halmesmaki E. Vascular endothelial growth factor is bound in amniotic fluid and maternal serum. Hum Reprod 1998;1346-51.
22. 22. Torry DS, Ahn H, Barnes EL, Torry RJ. PIGF: potential role in pregnancy. Am J Reprod Immunol 1999;41:79-85.
23. 23. Reuvekamp A, Velsing-Aarts FV, Poulina IE, Capello JJ, Duits AJ. Selective deficit of angiogenic growth factors characterises pregnancies compliated by pre-eclampsia. Br J Obstet Gynaecol 1999;106:1019-22.
24. 24. Livingston JC, McKinney ET, Haddad BR, Sibai BM. Plasma levels of vascular endothelial growth factor and placental growth factor are reduced in women with severe preeclampsia [abstract 68]. Am J Obstet Gynecol 2000;182 (1 Pt 2):S41.
25. 25. Wolf RB, Tarsa M, Cheung CY, Bogic LV. Increased VEGF gene expression in human fetal membranes as a mechanism for premature spontaneous rupture of the membranes [abstract 29]. J Soc Gynecol Investig 2000;7:50A.